Nanotein Technologies is a biotechnology company that develops drugs for immunotherapy.
Nanotein Technologies has raised $3.0M in total funding. The most recent round was Corporate Round. The last funding was announced in August 2025.
Nanotein Technologies's investors include Sartorius.
Nanotein Technologies is headquartered in Berkeley, United States.
Nanotein Technologies is a biotechnology company that develops drugs for immunotherapy.
Nanotein Technologies is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanotein Technologies — Funding & Investors." VCBacked, August 11, 2025, https://www.vcbacked.co/company/nanotein-technologies. Accessed August 14, 2026.
VCBacked. (2025). Nanotein Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nanotein-technologies
{{cite web |title=Nanotein Technologies — Funding & Investors |url=https://www.vcbacked.co/company/nanotein-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated